Chinese insurtech Huize to buy controlling stake in Vietnamese startup Global Care
June 21 2024 by Georgina Lee
-
Global funding for insurtech tops US$1.38bn in Q3 driven by AI-centred deals: Gallagher Re
- November 8
The number of deals struck in Q3 2024 fell to 77, the lowest in nearly four years.
-
Tokio Marine-backed ICEYE plans continued rollout across Asia as demand for satellite risk data continues
- October 29
Appetite for granular catastrophe-related information is now crucial in a market keen to keep a greater handle on cat exposures.
-
NFRA unveils special insurance initiative for Chinese tech enterprises
- October 1
The regulator's goal is to enhance offerings for businesses at various stages of their lifecycle in different areas, such as cybersecurity and R&D loss insurance.
-
Gen AI, digital infrastructure foundational to enhancing customer experience: FWD
- September 26
The Hong Kong insurance group's chief digital officer Ryan Kim shares how AI and technology can benefit insurers’ operations and distribution processes.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
